Evaluation status available after sign-in
About the journal
Diabetes Epidemiology and Management is an open-access journal published by Elsevier in France, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,000 EUR. Declared review time at DOAJ: 7 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2666-9706
- Country
- France
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,000 EUR
- Articles in DOAJ
- 225
- Declared review time
- 7 weeks
- Declared peer-review model
- other
Index listings
- DOAJ · 2021-12-02
- Indexing
- DOAJ
- APC
- 2,000 EUR
- Declared review time (DOAJ)
- 7 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
225
Most recent article
5 months ago
Average review time (journal-declared via DOAJ)
7weeks
Works in OpenAlex
244
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
17
i10-index
39
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2026-01-12
- Added to DOAJ
- 2021-12-02
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 84%
- ORCID iDs in current deposits
- 71%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918334488006676
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
LCC codes
RC648-665
Subject areas
- Diabetes Management and Research
- Diabetes Management and Research
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Diabetes Treatment and Management
Show all subjects (75)
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
- Diabetes Management and Education
- Diabetes and associated disorders
- Diabetes and associated disorders
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Pancreatic function and diabetes
- Chronic Disease Management Strategies
- Pancreatic function and diabetes
- Chronic Disease Management Strategies
- Diabetes and associated disorders
- Chronic Kidney Disease and Diabetes
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Metabolism, Diabetes, and Cancer
- Diet and metabolism studies
- Diet and metabolism studies
- Metabolism, Diabetes, and Cancer
- Legal case studies and regulations
- Diabetic Foot Ulcer Assessment and Management
- Diabetic Foot Ulcer Assessment and Management
- Mobile Health and mHealth Applications
- Legal case studies and regulations
- Mobile Health and mHealth Applications
- Liver Disease Diagnosis and Treatment
- COVID-19 Clinical Research Studies
- Retinal Diseases and Treatments
- Retinal Diseases and Treatments
- Liver Disease Diagnosis and Treatment
- Retinal Diseases and Treatments
- COVID-19 Clinical Research Studies
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Retinal Imaging and Analysis
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Blood Pressure and Hypertension Studies
- Retinal Imaging and Analysis
- Blood Pressure and Hypertension Studies
- Diabetic Foot Ulcer Assessment and Management
- Pancreatic function and diabetes
- Educational Robotics and Engineering
- Chronic Kidney Disease and Diabetes
- Educational Robotics and Engineering
- Chronic Kidney Disease and Diabetes
- COVID-19 Clinical Research Studies
- Gestational Diabetes Research and Management
- Dietary Effects on Health
- Dietary Effects on Health
- Health Systems, Economic Evaluations, Quality of Life
- Cardiovascular Function and Risk Factors
- Cardiovascular Function and Risk Factors
- Healthcare Systems and Public Health
- Retinal Imaging and Analysis
- Heart Failure Treatment and Management
- Oral microbiology and periodontitis research
- Mobile Health and mHealth Applications
- Glaucoma and retinal disorders
- Adipokines, Inflammation, and Metabolic Diseases
- COVID-19 and healthcare impacts
- Pharmaceutical Practices and Patient Outcomes
- Glaucoma and retinal disorders
- Dental Health and Care Utilization
- Medical Coding and Health Information
- Peripheral Artery Disease Management
- Dietary Effects on Health
- Dementia and Cognitive Impairment Research
Keywords (DOAJ)
- diabetes type 2
- diabetes type 1
- epidemiology
- quality of life
- digital data
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ